Cargando…
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient
We report here the sequence and functional characterization of a recombinantly expressed autoantibody (mAb 131) previously isolated from a myasthenia gravis patient by immortalization of thymic B cells using Epstein-Barr virus and TLR9 activation. The antibody is characterized by a high degree of so...
Autores principales: | Saxena, Abhishek, Stevens, Jo, Cetin, Hakan, Koneczny, Inga, Webster, Richard, Lazaridis, Konstantinos, Tzartos, Socrates, Vrolix, Kathleen, Nogales-Gadea, Gisela, Machiels, Barbie, Molenaar, Peter C., Damoiseaux, Jan, De Baets, Marc H., Simon-Keller, Katja, Marx, Alexander, Vincent, Angela, Losen, Mario, Martinez-Martinez, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663942/ https://www.ncbi.nlm.nih.gov/pubmed/29089519 http://dx.doi.org/10.1038/s41598-017-14350-8 |
Ejemplares similares
-
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020) -
Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis Patients
por: Kordas, Gregory, et al.
Publicado: (2014) -
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK
por: Yilmaz, Vuslat, et al.
Publicado: (2015) -
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
por: Lazaridis, Konstantinos, et al.
Publicado: (2020) -
Nomogram for short-term outcome assessment in AChR subtype generalized myasthenia gravis
por: Zhao, Rui, et al.
Publicado: (2021)